JPMorgan Chase & Co. Cuts H.B. Fuller (NYSE:FUL) Price Target to $50.00

H.B. Fuller (NYSE:FUL) had its price target lowered by JPMorgan Chase & Co. from $60.00 to $50.00 in a report published on Friday,Benzinga reports. The firm currently has an underweight rating on the specialty chemicals company’s stock.

Several other research firms have also commented on FUL. Citigroup lowered their price objective on H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. Seaport Res Ptn cut shares of H.B. Fuller from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 5th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of H.B. Fuller from $75.00 to $72.00 and set a “buy” rating on the stock in a research report on Wednesday, January 22nd. Finally, Vertical Research downgraded shares of H.B. Fuller from a “buy” rating to a “hold” rating in a research report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, H.B. Fuller has an average rating of “Hold” and a consensus target price of $70.00.

H.B. Fuller Stock Down 5.0 %

FUL stock opened at $54.76 on Friday. The company has a market capitalization of $2.97 billion, a P/E ratio of 23.70, a price-to-earnings-growth ratio of 1.13 and a beta of 1.41. H.B. Fuller has a 12 month low of $52.59 and a 12 month high of $87.67. The firm’s fifty day simple moving average is $58.31 and its 200-day simple moving average is $68.61. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.81 and a quick ratio of 1.16.

H.B. Fuller (NYSE:FUL) last posted its quarterly earnings results on Wednesday, March 26th. The specialty chemicals company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.49 by $0.05. The company had revenue of $788.66 million for the quarter, compared to analyst estimates of $769.55 million. H.B. Fuller had a net margin of 3.65% and a return on equity of 12.01%. The firm’s revenue was down 2.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.67 earnings per share. As a group, equities research analysts forecast that H.B. Fuller will post 4.07 earnings per share for the current year.

H.B. Fuller Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, February 20th. Shareholders of record on Thursday, February 6th were given a dividend of $0.2225 per share. This represents a $0.89 dividend on an annualized basis and a yield of 1.63%. The ex-dividend date of this dividend was Thursday, February 6th. H.B. Fuller’s dividend payout ratio is presently 44.50%.

Institutional Trading of H.B. Fuller

Several institutional investors have recently modified their holdings of FUL. Geode Capital Management LLC raised its position in shares of H.B. Fuller by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock worth $99,939,000 after purchasing an additional 18,734 shares during the last quarter. Lord Abbett & CO. LLC increased its stake in H.B. Fuller by 79.8% during the 3rd quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock worth $57,952,000 after buying an additional 324,056 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in shares of H.B. Fuller by 17.2% during the fourth quarter. Bank of New York Mellon Corp now owns 554,947 shares of the specialty chemicals company’s stock valued at $37,448,000 after acquiring an additional 81,558 shares during the last quarter. Kennedy Capital Management LLC lifted its position in shares of H.B. Fuller by 13.4% in the fourth quarter. Kennedy Capital Management LLC now owns 127,896 shares of the specialty chemicals company’s stock valued at $8,630,000 after acquiring an additional 15,100 shares in the last quarter. Finally, MetLife Investment Management LLC boosted its stake in shares of H.B. Fuller by 4.7% in the fourth quarter. MetLife Investment Management LLC now owns 33,058 shares of the specialty chemicals company’s stock worth $2,231,000 after acquiring an additional 1,472 shares during the last quarter. Institutional investors and hedge funds own 95.93% of the company’s stock.

H.B. Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.